TWEAK与原发性高血压患者心脏重塑的相关性
Correlation between TWEAK and cardiac remodeling in essential hypertensive patients

DOI: 10.6040/j.issn.1671-7554.0.2017.125

Keywords: 原发性高血压,肿瘤坏死因子样凋亡微弱诱导物,基质金属蛋白酶1,心脏重塑,
Essential hypertension,Tumor necrosis factor-like weak inducer of apoptosis,Matrix metalloproteinase 1,cardiac remodeling

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Richter B, Rychli K, Hohensinner PJ, et al. Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis(TWEAK)in advanced ischemic and non-ischemic heart failure[J]. Atherosclerosis, 2010, 213(2): 545-548.
[2]	Bergman MR, Kao RH, McCune SA, et al. Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats[J]. Am J Physiol, 1999, 277(2 Pt 2): 543-550.
[3]	王其磊, 任满意, 王德金, 等. TWEAK通过P38MAPK途径促进大鼠心肌成纤维细胞Ⅰ型胶原和MMP-1的表达[J]. 山东大学学报(医学版), 2012, 50(11): 43-47. WANG Qilei, REN Manyi, WANG Dejin, et al. TWEAK promotes expressions of collagen Ⅰ and matrix metalloproteinase-1 in rat cardiac fibroblasts via P38MAPK pathway[J]. Journal of Shandong University(Health Science), 2012, 50(11): 43-47.
[4]	钱志勇, 张赛丹, 钟小芹, 等. 左心房容积指数与高血压患者左心室舒张功能相关性探讨[J]. 中国现代医学杂志, 2011, 21(29): 3631-3634. QIAN Zhiyong, ZHANG Saidan, ZHONG Xiaoqin, et al. Evaluation relationship between left atrial volume index and left ventricular diastolic function in patients with hypertension[J]. China Jounal of Modern Medicine, 2011, 21(29): 3631-3634.
[5]	Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J]. N Engl J Med, 2002, 347(20): 1557-1565.
[6]	Winkles JA. The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting[J]. Nature reviews Drug discovery, 2008, 7(5): 411-425.
[7]	Wiley SR, Cassiano L, Lofton T, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis[J]. Immunity, 2001, 5(5): 837-846.
[8]	Burkly LC, Michaelson JS, Hahm K, et al. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease[J]. Cytokine, 2007, 40(1): 1-16.
[9]	Chorianopoulos E, Jarr K, Steen H, et al. Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome[J]. Clin Res Cardiol, 2010, 211(1): 322-326.
[10]	Jarr KU, Eschricht S, Burkly LC, et al. TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in mice[J]. Mediators inflamm, 2014, 2014: 131950. doi:10.1155/2011/131950.
[11]	Karadurmus N, Tapan S, Cakar M, et al. Lower plasma soluble TWEAK concentration in patients with newly diagnosed hypertension[J]. Clin Invest Med, 2012, 35(1): 20-26.
[12]	Novoyatleva T, Janssen W, Wietelmann A, et al. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy[J]. Cytokine, 2013, 64(1): 43-45.
[13]	徐忠阳, 王立启, 徐振兴, 等. RhoA/ROCK信号通路与原发性高血压患者血压变异性及颈动脉内膜中层厚度的相关性[J]. 山东大学学报(医学版), 2015, 53(2): 48-51. XU Zhongyang, WANG Liqi, XU Zhenxing, et al. Correlations among RhoA/ROCK signaling pathway, blood pressure variability and carotid artery intima-media thickness in essential hypertensive patients[J]. Journal of Shandong University(Health Science), 2015, 53(2): 48-51.
[14]	Mustonen E, Ruskoaho H, Rysa J. Thrombospondin-4,tumour necrosis factor like weak inducer of apoptosis(TWEAK)and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling[J]. AnnMed, 2012, 44(8): 793-804.
[15]	Martos R, Baugh J, Ledwidge M, et al. Evidence of increased myocardial collagen turnover linked to diastolic dysfunction[J]. Circulation, 2007, 115(7): 888-895.
[16]	Nagueh SF, Stetson SJ, Lakkis NM, et al. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy[J]. Circulation, 2001, 103(14): 1844-1850.
[17]	Chen HN, Wang DJ, Ren MY, et al. TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-small ka, CyrillicB pathway[J]. Mol Biol Rep, 2012, 39(8): 8231-8241.
[18]	巨媛媛, 任满意, 李睿, 等. TWEAK通过ERK1/2通路促进大鼠心肌成纤维细胞MMP2与Ⅰ型胶原表达[J]. 山东大学学报(医学版), 2016, 54(5): 23-28. JU Yuanyuan, REN Manyi, LI Rui, et al. Tumor necrosis factor-like weak inducer of apoptosis promotes expression of matrix metalloproteinase 2 and collagen Ⅰ in rat cardiac fibroblasts via the ERK1/2 signaling pathway[J]. Journal of Shandong University(Health Science), 2016, 54(5): 23-28.
[19]	Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease[J]. J Clin Invest, 2007, 117(3): 568-575.
[20]	Abeles AM, Pillinger MH. The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases[J]. Bull NYU Hosp Jt Dis, 2006, 64(1-2): 20-24.
[21]	Pachel C, Mathes D, Bayer B, et al. Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation[J]. PLoS One, 2013, 8(11): 78938.
[22]	Peng QL, Shu XM, Tian XL, et al. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis[J]. Arthritis Res Ther, 2014, 16(1): 26.
[23]	Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses[J]. Immunological reviews, 2011, 244(1): 99-114.
[24]	Wajant H. The TWEAK-Fn14 system as a potential drug target[J]. Br J Pharmacol, 2013, 170(4): 748-764.

Full-Text